[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GR3037011T3 - Vaccine composition containing polyribosylribitol phosphate and method for making same - Google Patents

Vaccine composition containing polyribosylribitol phosphate and method for making same

Info

Publication number
GR3037011T3
GR3037011T3 GR20010401748T GR20010401748T GR3037011T3 GR 3037011 T3 GR3037011 T3 GR 3037011T3 GR 20010401748 T GR20010401748 T GR 20010401748T GR 20010401748 T GR20010401748 T GR 20010401748T GR 3037011 T3 GR3037011 T3 GR 3037011T3
Authority
GR
Greece
Prior art keywords
composition containing
vaccine composition
making same
polyribosylribitol phosphate
polyribosylribitol
Prior art date
Application number
GR20010401748T
Other languages
English (en)
Inventor
Francois Arminjon
Jean-Rene Cartier
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9479510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3037011(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of GR3037011T3 publication Critical patent/GR3037011T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/831Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
GR20010401748T 1995-05-24 2001-10-25 Vaccine composition containing polyribosylribitol phosphate and method for making same GR3037011T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9506417A FR2734484B1 (fr) 1995-05-24 1995-05-24 Composition vaccinale liquide et procede de fabrication
PCT/FR1996/000791 WO1996037222A1 (fr) 1995-05-24 1996-05-24 Composition vaccinale comprenant du polyribosylribitol phosphate et son procede de fabrication

Publications (1)

Publication Number Publication Date
GR3037011T3 true GR3037011T3 (en) 2002-01-31

Family

ID=9479510

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401748T GR3037011T3 (en) 1995-05-24 2001-10-25 Vaccine composition containing polyribosylribitol phosphate and method for making same

Country Status (26)

Country Link
US (1) US6333036B1 (el)
EP (1) EP0828511B1 (el)
JP (1) JPH11505824A (el)
KR (1) KR100404312B1 (el)
CN (1) CN1152715C (el)
AT (1) ATE207365T1 (el)
BR (1) BR9608810C8 (el)
CA (1) CA2218764C (el)
CZ (1) CZ289810B6 (el)
DE (2) DE122011100030I1 (el)
DK (1) DK0828511T3 (el)
EA (1) EA000411B1 (el)
ES (1) ES2162067T3 (el)
FR (1) FR2734484B1 (el)
GR (1) GR3037011T3 (el)
HK (1) HK1017251A1 (el)
HU (1) HU223941B1 (el)
LU (1) LU91924I2 (el)
NL (1) NL300231I2 (el)
NO (2) NO319579B1 (el)
NZ (1) NZ309829A (el)
PL (1) PL185846B1 (el)
PT (1) PT828511E (el)
SK (1) SK282500B6 (el)
TR (1) TR199701424T1 (el)
WO (1) WO1996037222A1 (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
US6974581B1 (en) * 1998-12-15 2005-12-13 Aventis Pasteur Limited Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease
IL145209A0 (en) 2000-09-06 2002-06-30 Pfizer Prod Inc Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
EP1674087A1 (en) 2000-10-02 2006-06-28 Pfizer Products Inc. Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists
FR2828406B1 (fr) * 2001-08-08 2005-06-24 Aventis Pasteur Composition vaccinale bivalente havi
ES2775098T3 (es) 2002-10-11 2020-07-23 Glaxosmithkline Biologicals Sa Vacunas de polipéptidos para protección amplia contra linajes meningocócicos hipervirulentos
CN101926988B (zh) 2003-01-30 2014-06-04 诺华疫苗和诊断有限公司 抗多种脑膜炎球菌血清组的可注射性疫苗
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
AU2004277758A1 (en) 2003-10-02 2005-04-14 Novartis Vaccines And Diagnostics S.R.L. Liquid vaccines for multiple meningococcal serogroups
DK1689721T3 (da) * 2003-11-26 2010-09-20 Pfizer Prod Inc Aminopyrazolderivater som GSK-3-ihibitorer
GB0405787D0 (en) 2004-03-15 2004-04-21 Chiron Srl Low dose vaccines
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
JP5718545B2 (ja) 2004-04-30 2015-05-13 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル 髄膜炎菌結合体ワクチン接種
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
CN101801343A (zh) * 2007-07-26 2010-08-11 圣诺菲·帕斯图尔有限公司 抗原佐剂组合物及其方法
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
PE20100366A1 (es) 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
PE20100365A1 (es) * 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion
US7814991B2 (en) * 2009-01-28 2010-10-19 Gas Technology Institute Process and apparatus for subterranean drilling
EP2411048B1 (en) 2009-03-24 2020-05-06 GlaxoSmithKline Biologicals SA Adjuvanting meningococcal factor h binding protein
SG183806A1 (en) * 2010-03-29 2012-10-30 Novartis Ag Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant
RU2705163C2 (ru) 2011-01-05 2019-11-05 Бхарат Байотек Интернэшнл Лимитед Комбинированная семивалентная вакцина
CN105007936B (zh) 2013-03-08 2018-10-02 扬森疫苗与预防公司 无细胞百日咳疫苗
WO2022224966A1 (ja) 2021-04-20 2022-10-27 Kmバイオロジクス株式会社 6種混合液状ワクチン組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
DK0835663T3 (da) * 1992-05-23 2010-02-01 Glaxosmithkline Biolog Sa Kombinerede vacciner omfattende Hepatitis B overfladeantigen og andre antigener

Also Published As

Publication number Publication date
EP0828511A1 (fr) 1998-03-18
NO2011019I1 (no) 2011-09-26
TR199701424T1 (xx) 1998-03-21
BR9608810A (pt) 1999-08-31
HK1017251A1 (en) 1999-11-19
HUP9901432A2 (hu) 1999-08-30
SK282500B6 (sk) 2002-10-08
NL300231I2 (nl) 2006-09-01
JPH11505824A (ja) 1999-05-25
NL300231I1 (nl) 2006-07-03
US6333036B1 (en) 2001-12-25
HUP9901432A3 (en) 2000-03-28
MX9709011A (es) 1998-03-31
KR100404312B1 (ko) 2004-02-11
NO319579B1 (no) 2005-08-29
CA2218764A1 (fr) 1996-11-28
NO975366D0 (no) 1997-11-21
EA000411B1 (ru) 1999-06-24
AU6008696A (en) 1996-12-11
PL323457A1 (en) 1998-03-30
PT828511E (pt) 2002-02-28
NO975366L (no) 1997-11-21
AU708777B2 (en) 1999-08-12
CZ359797A3 (cs) 1999-06-16
EA199700419A1 (ru) 1998-06-25
LU91924I2 (fr) 2012-02-21
ATE207365T1 (de) 2001-11-15
NO2011019I2 (no) 2015-05-18
KR19990014919A (ko) 1999-02-25
CN1152715C (zh) 2004-06-09
EP0828511B1 (fr) 2001-10-24
SK152997A3 (en) 1998-07-08
WO1996037222A1 (fr) 1996-11-28
DE122011100030I1 (de) 2011-12-08
CZ289810B6 (cs) 2002-04-17
HU223941B1 (hu) 2005-03-29
PL185846B1 (pl) 2003-08-29
BR9608810C8 (pt) 2014-07-08
NZ309829A (en) 1999-06-29
DE69620271T2 (de) 2002-07-18
FR2734484A1 (fr) 1996-11-29
CN1190898A (zh) 1998-08-19
DK0828511T3 (da) 2002-02-18
FR2734484B1 (fr) 1997-06-27
CA2218764C (fr) 2011-01-11
ES2162067T3 (es) 2001-12-16
DE69620271D1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
HK1017251A1 (en) Vaccine composition containing polyribosylribitol phosphate and method for making same.
IS3753A7 (is) Endurbætt aðferð og samsetning bóluefnis
AU561978B2 (en) Haemophilus influenzae b polysaccharide-diptheria toxoid conjugate vaccine
EP0914153B8 (en) Multivalent dtp-polio vaccines
HK1041825A1 (en) A polysaccharide-protein conjugate or oligosaccharide-protein conjugate, a method for producing the same, and its uses thereof
ZA917771B (en) Oligosaccharide conjugate vaccines
PL316434A1 (en) Oligonucleotidic phosphoramides n3'-p5', their compositions, synthesising and hydridising methods as well as immunological properties in respect to nuclease
ES8403724A1 (es) Un procedimiento para preparar un complejo inmunogeno no covalentes de polisacarido-proteina, y obtenido a partir de capsulas bacterianas.
IL121585A0 (en) Immunogenic and immunostimulatory oligosaccharide compositions and methods of preparing and using them
EP0338265A3 (en) Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine
AU3760795A (en) Synthesis of typhoid fever vaccine from a plant or fruit polysaccharide
AU6709500A (en) Trehalose producing cells as vaccines
ES2115550A1 (es) Vacuna anti-pasteurella piscicida (di)para la prevencion de la enfermedad pasteurelosis en dorada y lubina y procedimiento de obtencion. .
MX9606079A (es) Lubricante para composiciones de polvo metalico, composicion de polvo metalico, que contiene el lubricante, metodo para hacer productos concresionados por medio de usar el lubricante y uso del mismo.